Patent life is too short for delays.

Trial delays have become the norm. But do they have to be? Don’t put up with poor performance. For 25 years we have built such trusted relationships with biotech sponsors, with 90% of our customers being repeat and referral.

See how can we help you

Save Time

We know that the industry is riddled with delays. In fact, 90% of trials aren’t on schedule. But at PSI, we deliver on-time, over and over again. In fact, we’re even known to enroll ahead of time.

Save Money

Your product is important, and your team has the potential to change lives for patients all around the world. Save money by choosing the right CRO from the beginning. Our budgets are tried and true, and we’ll be on-target the entire time.

Save Reputation

We deliver quality, and we deliver on-time. Our teams work tirelessly to ensure your study, and the reputation of your product will speak volumes.

On-time enrollment in pivotal Phase 2 & 3 clinical trials

> 90% repeat and referral rate for clients

Extensive and diverse team of experts across 50+ countries

How does it happen?

We meet deadlines and enrollment milestones, time and time and time again. In fact, you could say our obsession with timelines is something of an unfair advantage. We’ve built a name by coming to the rescue when trials fall behind and sponsors have to start from scratch. “We Can Do Hard Things” is one of our rallying cries, and it’s true.

On-time delivery goes hand in hand with world class service. In an industry where being behind schedule is considered par for the course, we dare to buck the trend. It’s time to choose the CRO you can trust.

Ready to push your trial ahead?

Here are 3 simple first steps on the way to a successful trial:

1.
Contact us to schedule a call

2.
Submit a proposal

3.
Launch your trial on time

"PSI was flexible to meet the various challenges in clinical trial conduct. The rapid enrollment of patients and the quick study close out allowed on-time study completion."
Sue Cammarata, Chief Medical Officer at Melinta

Our latest case studies